|
CN109305980A
|
|
A kind of boric acid ester compound, its preparation method and use
|
|
CN102659630A
|
|
Hydroxamic acid compound and preparation method as well as application thereof
|
|
CN101601859A
|
|
Application of nattokinase in preparing cerebral protective agent type drugs
|
|
CN101744809A
|
|
Combined drug of anethole and fenofibrate drugs
|
|
CN101541780A
|
|
Fibrate carboxylate compounds, preparation methods and uses thereof
|
|
CN101100469A
|
|
Novel crystal of doripenem, preparation method and use thereof
|
|
CN101073602A
|
|
Medicinal composition for treating or improving liver function, its production and use
|
|
CN101032541A
|
|
Echinacea purpurea extract and the preparing method and the content measuring method
|
|
CN101108246A
|
|
Thymus gland pentapeptide oral intestine-dissolved formulated product and method of preparing the same and use thereof
|
|
CN1839920A
|
|
Astragaloside injection and preparation method thereof
|
|
CN1854148A
|
|
Astragalus total heteroside extract and its production
|
|
CN102100731A
|
|
Novel application of astragalus mongholicus saponins extract and preparation method thereof
|
|
CN1958794A
|
|
Method for preparing mutant code cDNA of apoptosis induction ligand related to human tumor necrosis factor, and application
|
|
CN1919214A
|
|
Monascus soft capsule and its preparation method
|
|
CN1810270A
|
|
Preparation process of total salvianolic acid
|
|
CN102091125A
|
|
Method for preparing total salvianolic acid
|
